Started By
Message

re: Bought into a sinking ship stock

Posted on 11/2/23 at 5:09 pm to
Posted by LSUcam7
FL
Member since Sep 2016
7918 posts
Posted on 11/2/23 at 5:09 pm to
quote:

bayoubengals88


What’s your starting point for biotechs? Do you stick with a particular area within the sector?

It’s such a volatile and speculative space hard to know which small/mid size companies are executing well.

Then understanding pipelines is like a biochem class. For each company.
Posted by bayoubengals88
LA
Member since Sep 2007
19248 posts
Posted on 11/2/23 at 5:30 pm to
Now days, I look for companies that target rare diseases and have at least one fda approved drug with cash on hand for 18 months or so and a minimal history of dilution.

MIRM is a great example and ALBO was a great example.
I’ve posted about both here.

Still hopeful for AKBA too.
Posted by bayoubengals88
LA
Member since Sep 2007
19248 posts
Posted on 11/2/23 at 5:41 pm to
quote:

Then understanding pipelines is like a biochem class. For each company.
Indeed. That’s why I don’t value pre clinical assets. I simply don’t know how.

Voclosporin being one of the few examples.
first pageprev pagePage 1 of 1Next pagelast page
refresh

Back to top
logoFollow TigerDroppings for LSU Football News
Follow us on Twitter, Facebook and Instagram to get the latest updates on LSU Football and Recruiting.

FacebookTwitterInstagram